Oncological care organisation during COVID-19 outbreak
| العنوان: | Oncological care organisation during COVID-19 outbreak |
|---|---|
| المؤلفون: | Khalil Zaman, Miguel Martin, Daniele Generali, Massimo Cristofanilli, Marc Peeters, Sabino De Placido, Javier Cortes, Sylvie Rottey, Thomas Ruhstaller, Hope S. Rugo, Concetta Elisa Onesti, Rupert Bartsch, Ahmad Awada, Guy Jerusalem, Sara A. Hurvitz, Jean Pascal Machiels, Volkmar Müller, Fabio Puglisi, Nadia Harbeck, Guy Berchem, Marco Tagliamento, Pierfranco Conte, Mario Campone, Hans Wildiers, Vivianne C. G. Tjan-Heijnen |
| المساهمون: | Institut Català de la Salut, [Onesti CE] Department of Medical Oncology, CHU de Liège, Liege, Belgium. Laboratory of Human Genetics, GIGA Research Institute and University of Liège, Liège, Belgium. [Rugo HS] Department of Medicine and Division of Oncology, University of California San Francisco, Comprehensive Cancer Center, San Francisco, California, USA. [Generali D] UO Patologia Mammaria e Ricerca Traslazionale, Breast Unit, Azienda Socio Sanitaria Territoriale di Cremona, Cremona, Italy. University of Trieste, Trieste, Italy. [Peeters M] Oncology Department, University Hospital Antwerp (UZA), Antwerp, Belgium. [Zaman K] Oncology Department, CHUV - Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland. [Wildiers H] Department of General Medical Oncology, University Hospitals Leuven, Leuven, Belgium. [Cortes J] Servei d’Oncologia, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. IOB Institute of Oncology, Madrid, Spain, Vall d'Hebron Barcelona Hospital Campus, UCL - SSS/IREC/MIRO - Pôle d'imagerie moléculaire, radiothérapie et oncologie, UCL - (SLuc) Centre du cancer, UCL - (SLuc) Unité d'oncologie médicale, Interne Geneeskunde, MUMC+: MA Medische Oncologie (9), RS: GROW - R3 - Innovative Cancer Diagnostics & Therapy, Onesti, Concetta Elisa, Rugo, Hope S, Generali, Daniele, Peeters, Marc, Zaman, Khalil, Wildiers, Han, Harbeck, Nadia, Martin, Miguel, Cristofanilli, Massimo, Cortes, Javier, Tjan-Heijnen, Vivianne, Hurvitz, Sara A, Berchem, Guy, Tagliamento, Marco, Campone, Mario, Bartsch, Rupert, De Placido, Sabino, Puglisi, Fabio, Rottey, Sylvie, Müller, Volkmar, Ruhstaller, Thoma, Machiels, Jean-Pascal, Conte, Pierfranco, Awada, Ahmad, Jerusalem, Guy, Onesti, C. E., Rugo, H. S., Generali, D., Peeters, M., Zaman, K., Wildiers, H., Harbeck, N., Martin, M., Cristofanilli, M., Cortes, J., Tjan-Heijnen, V., Hurvitz, S. A., Berchem, G., Tagliamento, M., Campone, M., Bartsch, R., De Placido, S., Puglisi, F., Rottey, S., Muller, V., Ruhstaller, T., Machiels, J. -P., Conte, P., Awada, A., Jerusalem, G. |
| المصدر: | Scientia Dipòsit Digital de Documents de la UAB Universitat Autònoma de Barcelona ESMO open, vol 5, iss 4 ESMO Open, Vol. 5, no. 4, p. e000853 [1-8] (2020) ESMO Open, 5(4):000853. BMJ Publishing Group ESMO OPEN ESMO Open ESMO Open, 5 (4 ESMO Open, Vol 5, Iss 4 (2020) ESMO open, vol. 5, no. 4, pp. e000853 |
| بيانات النشر: | Elsevier BV, 2020. |
| سنة النشر: | 2020 |
| مصطلحات موضوعية: | Cancer Research, Oncologia, Day care, Medical Oncology, COVID-19 (Malaltia), RECOMMENDATIONS, Assistència sanitària, Neoplasms, Health care, Medicine and Health Sciences, virosis::infecciones por virus ARN::infecciones por Nidovirales::infecciones por Coronaviridae::infecciones por Coronavirus [ENFERMEDADES], Medicine, Viral, Health Occupations::Medicine::Internal Medicine::Medical Oncology [DISCIPLINES AND OCCUPATIONS], Cancer, COVID-19, oncological care, Betacoronavirus, Cancer Care Facilities, Coronavirus Infections, Delivery of Health Care, Disinfection, Europe, Health Care Surveys, Humans, Pandemics, Personal Protective Equipment, Pneumonia, Viral, SARS-CoV-2, Triage, United States, Visitors to Patients, Health Care (Public Health) [PUBLIC HEALTH], Virus Diseases::RNA Virus Infections::Nidovirales Infections::Coronaviridae Infections::Coronavirus Infections [DISEASES], lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens, CANCER, Oncology, Medical emergency, Human, United State, Telemedicine, Cancer Care Facilities/organization & administration, Cancer Care Facilities/statistics & numerical data, Coronavirus Infections/diagnosis, Coronavirus Infections/epidemiology, Coronavirus Infections/prevention & control, Europe/epidemiology, Medical Oncology/statistics & numerical data, Neoplasms/therapy, Pandemics/prevention & control, Pneumonia, Viral/diagnosis, Pneumonia, Viral/epidemiology, Pneumonia, Viral/prevention & control, United States/epidemiology, atención a la salud (salud pública) [SALUD PÚBLICA], SARS-COV-2, lcsh:RC254-282, profesiones sanitarias::medicina::medicina interna::oncología médica [DISCIPLINAS Y OCUPACIONES], Clinical Research, Behavioral and Social Science, Personal protective equipment, Betacoronaviru, Pandemic, Cancer Care Facilitie, Coronavirus Infection, business.industry, Prevention, Généralités, Pneumonia, medicine.disease, Good Health and Well Being, Health Care Survey, Neoplasm, Observational study, Human medicine, business, Patient education |
| الوصف: | Background COVID-19 appeared in late 2019, causing a pandemic spread. This led to a reorganisation of oncology care in order to reduce the risk of spreading infection between patients and healthcare staff. Here we analysed measures taken in major oncological units in Europe and the USA. Methods A 46-item survey was sent by email to representatives of 30 oncological centres in 12 of the most affected countries. The survey inquired about preventive measures established to reduce virus spread, patient education and processes employed for risk reduction in each oncological unit. Results Investigators from 21 centres in 10 countries answered the survey between 10 April and 6 May 2020. A triage for patients with cancer before hospital or clinic visits was conducted by 90.5% of centres before consultations, 95.2% before day care admissions and in 100% of the cases before overnight hospitalisation by means of phone calls, interactive online platforms, swab test and/or chest CT scan. Permission for caregivers to attend clinic visits was limited in many centres, with some exceptions (ie, for non-autonomous patients, in the case of a new diagnosis, when bad news was expected and for terminally ill patients). With a variable delay period, the use of personal protective equipment was unanimously mandatory, and in many centres, only targeted clinical and instrumental examinations were performed. Telemedicine was implemented in 76.2% of the centres. Separated pathways for COVID-19-positive and COVID-19-negative patients were organised, with separate inpatient units and day care areas. Self-isolation was required for COVID-19-positive or symptomatic staff, while return to work policies required a negative swab test in 76.2% of the centres. Conclusion Many pragmatic measures have been quickly implemented to deal with the health emergency linked to COVID-19, although the relative efficacy of each intervention should be further analysed in large observational studies. SCOPUS: ar.j info:eu-repo/semantics/published |
| وصف الملف: | application/pdf; Print; 1 full-text file(s): application/pdf |
| تدمد: | 2059-7029 |
| الوصول الحر: | https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f342599e4dce3a8d76d169e0c3738951Test https://doi.org/10.1136/esmoopen-2020-000853Test |
| حقوق: | OPEN |
| رقم الانضمام: | edsair.doi.dedup.....f342599e4dce3a8d76d169e0c3738951 |
| قاعدة البيانات: | OpenAIRE |
| تدمد: | 20597029 |
|---|